|
NDC00085-3320-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Schering-plough Corporation
|
|
Quote
|
|
NDC00085-3320-35
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Schering-plough Corporation
|
|
Quote
|
|
NDC00378-9112-93
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
NITRODISC
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Roberts Pharmaceutical Corp
|
|
Quote
|
|
NDC49730-0122-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Hercon Company, Inc
|
|
Quote
|
|
NDC00904-5496-46
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC00089-0303-02
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
3m Company Health Care/mfg
|
|
Quote
|
|
NDC00089-1303-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
3m Company Health Care/mfg
|
|
Quote
|
|
NDC00025-2068-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Roberts Pharmaceutical Corp
|
|
Quote
|
|
NDC54092-0344-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Roberts Pharmaceutical Corp
|
|
Quote
|
|
NDC62794-0204-93
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Mylan Bertek Pharmaceuticals Inc
|
|
Quote
|
|
NDC00085-3320-35
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Schering-plough Corporation
|
|
Quote
|
|
NDC00085-3320-35
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Schering-plough Corporation
|
|
Quote
|
|
NDC00378-9112-93
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
NITRODISC
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Roberts Pharmaceutical Corp
|
|
Quote
|
|
NDC49730-0122-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Hercon Company, Inc
|
|
Quote
|
|
NDC00089-0303-02
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
3m Company Health Care/mfg
|
|
Quote
|
|
NDC00089-1303-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
3m Company Health Care/mfg
|
|
Quote
|
|
NDC00904-5496-46
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC00025-2068-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Roberts Pharmaceutical Corp
|
|
Quote
|
|
NDC54092-0344-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Roberts Pharmaceutical Corp
|
|
Quote
|
|
NDC62794-0204-93
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Mylan Bertek Pharmaceuticals Inc
|
|
Quote
|
|
NDC00085-3320-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Schering-plough Corporation
|
|
Quote
|
|
NDC00085-3320-35
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Schering-plough Corporation
|
|
Quote
|
|
NDC00378-9112-93
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
NITRODISC
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Roberts Pharmaceutical Corp
|
|
Quote
|
|
NDC49730-0122-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Hercon Company, Inc
|
|
Quote
|
|
NDC00089-0303-02
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
3m Company Health Care/mfg
|
|
Quote
|
|
NDC00089-1303-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
3m Company Health Care/mfg
|
|
Quote
|
|
NDC00904-5496-46
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC00025-2068-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Roberts Pharmaceutical Corp
|
|
Quote
|
|
NDC54092-0344-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Roberts Pharmaceutical Corp
|
|
Quote
|
|
NDC62794-0204-93
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Mylan Bertek Pharmaceuticals Inc
|
|
Quote
|
|
NDC00085-3320-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Schering-plough Corporation
|
|
Quote
|
|
NDC00085-3320-35
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Schering-plough Corporation
|
|
Quote
|
|
NDC00378-9112-93
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
NITRODISC
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Roberts Pharmaceutical Corp
|
|
Quote
|
|
NDC49730-0122-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Hercon Company, Inc
|
|
Quote
|
|
NDC00089-0303-02
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
3m Company Health Care/mfg
|
|
Quote
|
|
NDC00089-1303-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
3m Company Health Care/mfg
|
|
Quote
|
|
NDC00904-5496-46
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC00025-2068-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Roberts Pharmaceutical Corp
|
|
Quote
|
|
NDC54092-0344-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Roberts Pharmaceutical Corp
|
|
Quote
|
|
NDC62794-0204-93
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Mylan Bertek Pharmaceuticals Inc
|
|
Quote
|
|
NDC00085-3320-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Schering-plough Corporation
|
|
Quote
|
|
NDC00085-3320-35
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Schering-plough Corporation
|
|
Quote
|
|
NORPACSE CR
|
6505-01-158-2170
|
Disopyramide Phosphate Extended |
Pharmacia & Upjohn Inc
|
|
Quote
|
|
NDC00025-2732-31
|
6505-01-158-2170
|
Disopyramide Phosphate Extended |
Pharmacia & Upjohn Inc
|
|
Quote
|
|
NORPACE CR
|
6505-01-158-2170
|
Disopyramide Phosphate Extended |
Searle G D and Co
|
|
Quote
|
|
NDC00025-2732-31
|
6505-01-158-2170
|
Disopyramide Phosphate Extended |
Searle G D and Co
|
|
Quote
|
|
RENALYTE RX 119
|
6505-01-158-3297
|
Concentrat Hemodialysis Solution |
Cobe Laboratories Inc
|
|
Quote
|
|
12-119-055
|
6505-01-158-3297
|
Concentrat Hemodialysis Solution |
Cobe Laboratories Inc
|
|
Quote
|
|
NDC00603-5168-21
|
6505-01-158-3628
|
Usp Phenobarbital Tablets |
Generics Bidco I, Llc
|
|
Quote
|
|
NDC63304-0744-01
|
6505-01-158-3628
|
Usp Phenobarbital Tablets |
Ranbaxy Pharmaceuticals Inc
|
|
Quote
|
|
NDC54868-3381-00
|
6505-01-158-3628
|
Usp Phenobarbital Tablets |
Medical and Safety Group Inc
|
|
Quote
|
|
NDC00054-8707-25
|
6505-01-158-3628
|
Usp Phenobarbital Tablets |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
EVAC-Q-KWIK
|
6505-01-158-4346
|
Preradiographic Exa Laxative Kit |
Savage Laboratories Div of Altana
|
|
Quote
|
|
NDC00281-0297-76
|
6505-01-158-4346
|
Preradiographic Exa Laxative Kit |
Savage Laboratories Div of Altana
|
|
Quote
|
|
NDC00013-2189-00
|
6505-01-158-4346
|
Preradiographic Exa Laxative Kit |
Erbamont Inc
|
|
Quote
|
|
EVAC-Q-KWIK
|
6505-01-158-4346
|
Preradiographic Exa Laxative Kit |
Savage Laboratories Div of Altana
|
|
Quote
|
|
NDC00281-0297-76
|
6505-01-158-4346
|
Preradiographic Exa Laxative Kit |
Savage Laboratories Div of Altana
|
|
Quote
|
|
NDC00013-2189-00
|
6505-01-158-4346
|
Preradiographic Exa Laxative Kit |
Erbamont Inc
|
|
Quote
|
|
NORPACE CR
|
6505-01-158-6361
|
Disopyramide Phosphate Extended |
Searle G D and Co
|
|
Quote
|
|
NDC00025-2742-31
|
6505-01-158-6361
|
Disopyramide Phosphate Extended |
Pharmacia & Upjohn Inc
|
|
Quote
|
|
NDC00025-2742-31
|
6505-01-158-6361
|
Disopyramide Phosphate Extended |
Searle G D and Co
|
|
Quote
|
|
NDC00025-2742-31
|
6505-01-158-6361
|
Disopyramide Phosphate Extended |
Pharmacia & Upjohn Inc
|
|
Quote
|
|
NDC00025-2742-31
|
6505-01-158-6361
|
Disopyramide Phosphate Extended |
Searle G D and Co
|
|
Quote
|
|
NORPACE CR
|
6505-01-158-6361
|
Disopyramide Phosphate Extended |
Searle G D and Co
|
|
Quote
|
|
NDC00025-2742-31
|
6505-01-158-6361
|
Disopyramide Phosphate Extended |
Pharmacia & Upjohn Inc
|
|
Quote
|
|
NDC00025-2742-31
|
6505-01-158-6361
|
Disopyramide Phosphate Extended |
Searle G D and Co
|
|
Quote
|
|
NORPACE CR
|
6505-01-158-6361
|
Disopyramide Phosphate Extended |
Searle G D and Co
|
|
Quote
|
|
NDC00025-2742-31
|
6505-01-158-6361
|
Disopyramide Phosphate Extended |
Pharmacia & Upjohn Inc
|
|
Quote
|
|
NDC00025-2742-31
|
6505-01-158-6361
|
Disopyramide Phosphate Extended |
Searle G D and Co
|
|
Quote
|
|
NORPACE CR
|
6505-01-158-6361
|
Disopyramide Phosphate Extended |
Searle G D and Co
|
|
Quote
|
|
NDC00002-1691-25
|
6505-01-158-6811
|
Usp Protamine Sulfate Injection |
Eli Lilly and Company
|
|
Quote
|
|
NDC00002-1691-25
|
6505-01-158-6811
|
Usp Protamine Sulfate Injection |
Eli Lilly and Company
|
|
Quote
|
|
NDC00002-1691-25
|
6505-01-158-6811
|
Usp Protamine Sulfate Injection |
Eli Lilly and Company
|
|
Quote
|
|
LANATUSS EXPECTORANT
|
6505-01-158-6812
|
Guaifen Chlorpheniramine Maleate |
Lannett Company, Inc.
|
|
Quote
|
|
NDC00527-0808-28
|
6505-01-158-6812
|
Guaifen Chlorpheniramine Maleate |
Lannett Company, Inc.
|
|
Quote
|
|
LANATUSS EXPECTORANT
|
6505-01-158-6812
|
Guaifen Chlorpheniramine Maleate |
Lannett Company, Inc.
|
|
Quote
|
|
NDC00527-0808-28
|
6505-01-158-6812
|
Guaifen Chlorpheniramine Maleate |
Lannett Company, Inc.
|
|
Quote
|
|
LANATUSS EXPECTORANT
|
6505-01-158-6812
|
Guaifen Chlorpheniramine Maleate |
Lannett Company, Inc.
|
|
Quote
|
|
NDC00527-0808-28
|
6505-01-158-6812
|
Guaifen Chlorpheniramine Maleate |
Lannett Company, Inc.
|
|
Quote
|
|
TRAVASOL 10%
|
6505-01-158-6813
|
Amino Acid Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
1A6626
|
6505-01-158-6813
|
Amino Acid Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-0629-06
|
6505-01-158-6813
|
Amino Acid Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
TRAVASOL 10%
|
6505-01-158-6813
|
Amino Acid Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
1A6626
|
6505-01-158-6813
|
Amino Acid Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-0629-06
|
6505-01-158-6813
|
Amino Acid Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
TRAVASOL 10%
|
6505-01-158-6813
|
Amino Acid Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
1A6626
|
6505-01-158-6813
|
Amino Acid Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-0629-06
|
6505-01-158-6813
|
Amino Acid Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC01490-0039-04
|
6505-01-158-7615
|
Bismuth Subsalicylate Suspension |
Cardinal Health 200, Llc
|
|
Quote
|
|
NDC01490-0039-04
|
6505-01-158-7615
|
Bismuth Subsalicylate Suspension |
Procter & Gamble Pharmaceuticals
|
|
Quote
|
|
NDC01490-0039-04
|
6505-01-158-7615
|
Bismuth Subsalicylate Suspension |
Procter & Gamble Pharmaceuticals
|
|
Quote
|
|
NDC01490-0039-04
|
6505-01-158-7615
|
Bismuth Subsalicylate Suspension |
Cardinal Health 200, Llc
|
|
Quote
|
|
CYTOXAN
|
6505-01-158-7889
|
U Cyclophosphamide For Injection |
Mead Johnson & Company, Llc
|
|
Quote
|
|
NEOSAR
|
6505-01-158-7889
|
U Cyclophosphamide For Injection |
Erbamont Inc
|
|
Quote
|
|
NDC00015-0505-41
|
6505-01-158-7889
|
U Cyclophosphamide For Injection |
Mead Johnson & Company, Llc
|
|
Quote
|
|
NDC00013-5636-70
|
6505-01-158-7889
|
U Cyclophosphamide For Injection |
Erbamont Inc
|
|
Quote
|
|
CYTOXAN
|
6505-01-158-7889
|
U Cyclophosphamide For Injection |
Mead Johnson & Company, Llc
|
|
Quote
|
|
NEOSAR
|
6505-01-158-7889
|
U Cyclophosphamide For Injection |
Erbamont Inc
|
|
Quote
|
|
NDC00015-0505-41
|
6505-01-158-7889
|
U Cyclophosphamide For Injection |
Mead Johnson & Company, Llc
|
|
Quote
|
|
NDC00013-5636-70
|
6505-01-158-7889
|
U Cyclophosphamide For Injection |
Erbamont Inc
|
|
Quote
|
|
NDC00407-0044-01
|
6505-01-158-8001
|
Metrizamide For Injection |
Ge Healthcare Inc.
|
|
Quote
|
|
NDC00407-0044-01
|
6505-01-158-8001
|
Metrizamide For Injection |
Amersham Health Inc.
|
|
Quote
|
|
STREPTASE
|
6505-01-158-8002
|
Streptokinase For Injection |
Asd Specialty Healthcare, Inc.
|
|
Quote
|
|
NDC00053-1770-01
|
6505-01-158-8002
|
Streptokinase For Injection |
Asd Specialty Healthcare, Inc.
|
|
Quote
|
|
STREPTASE
|
6505-01-158-8002
|
Streptokinase For Injection |
Asd Specialty Healthcare, Inc.
|
|
Quote
|
|
NDC00053-1770-01
|
6505-01-158-8002
|
Streptokinase For Injection |
Asd Specialty Healthcare, Inc.
|
|
Quote
|
|
METOPIRONE
|
6505-01-158-8003
|
Usp Metyrapone Tablets |
Ciba-geigy Corp
|
|
Quote
|
|
NDC00083-0130-11
|
6505-01-158-8003
|
Usp Metyrapone Tablets |
Ciba-geigy Corp
|
|
Quote
|
|
METOPIRONE
|
6505-01-158-8003
|
Usp Metyrapone Tablets |
Ciba-geigy Corp
|
|
Quote
|
|
NDC00083-0130-11
|
6505-01-158-8003
|
Usp Metyrapone Tablets |
Ciba-geigy Corp
|
|
Quote
|
|
5M7066
|
6505-01-159-0474
|
Concentrat Hemodialysis Solution |
Baxter Healthcare Corp
|
|
Quote
|
|
DIASOL
|
6505-01-159-0474
|
Concentrat Hemodialysis Solution |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00536-3938-10
|
6505-01-159-0962
|
Usp Isosorbide Dinitrate Tablets |
Rugby Group Inc
|
|
Quote
|
|
ACCUMED
|
6505-01-159-0963
|
Usp Sodium Chloride Injection |
B Braun Medical Inc
|
|
Quote
|
|
NDC00264-1800-00
|
6505-01-159-0963
|
Usp Sodium Chloride Injection |
B Braun Medical Inc
|
|
Quote
|
|
S8000
|
6505-01-159-0963
|
Usp Sodium Chloride Injection |
B Braun Medical Inc
|
|
Quote
|
|
2A0256
|
6505-01-159-1763
|
Usp Dextrose Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-0035-06
|
6505-01-159-1763
|
Usp Dextrose Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
DIANEAL 137
|
6505-01-159-2964
|
Peritoneal Dialysis Solution |
Baxter Healthcare Corp
|
|
Quote
|
|
5B5704
|
6505-01-159-2964
|
Peritoneal Dialysis Solution |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00941-0383-04
|
6505-01-159-2964
|
Peritoneal Dialysis Solution |
Baxter Healthcare Corp
|
|
Quote
|
|
DIANEAL 137
|
6505-01-159-2965
|
Peritoneal Dialysis Solution |
Baxter Healthcare Corp
|
|
Quote
|
|
5B5354
|
6505-01-159-2965
|
Peritoneal Dialysis Solution |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00941-0379-04
|
6505-01-159-2965
|
Peritoneal Dialysis Solution |
Baxter Healthcare Corp
|
|
Quote
|
|
POLY-VI-SOL-W/IRON
|
6505-01-159-3638
|
Multivitamin And Iron Oral Solut |
Mead Johnson & Company, Llc
|
|
Quote
|
|
NDC00087-0405-01
|
6505-01-159-3638
|
Multivitamin And Iron Oral Solut |
Mead Johnson & Company, Llc
|
|
Quote
|
|
TIGAN
|
6505-01-159-3647
|
Trimethobenzamide Hydrochloride |
King Pharmaceuticals Inc
|
|
Quote
|
|
NDC00029-4082-30
|
6505-01-159-3647
|
Trimethobenzamide Hydrochloride |
King Pharmaceuticals Inc
|
|
Quote
|
|
TIGAN CAPSULES
|
6505-01-159-3648
|
Trimethobenzamide Hydrochloride |
King Pharmaceuticals Inc
|
|
Quote
|
|
TIGAN
|
6505-01-159-3648
|
Trimethobenzamide Hydrochloride |
King Pharmaceuticals Inc
|
|
Quote
|
|
NDC00029-4083-32
|
6505-01-159-3648
|
Trimethobenzamide Hydrochloride |
King Pharmaceuticals Inc
|
|
Quote
|
|
5B5344
|
6505-01-159-3649
|
Peritoneal Dialysis Solution |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00941-0377-04
|
6505-01-159-3649
|
Peritoneal Dialysis Solution |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC53905-0281-10
|
6505-01-159-4570
|
Daunorubicin Hydrochloride For I |
Novartis Vaccines and Diagnostics,
|
|
Quote
|
|
NDC63323-0119-08
|
6505-01-159-4570
|
Daunorubicin Hydrochloride For I |
American Pharmaceutical Partners
|
|
Quote
|
|
NDC55390-0805-10
|
6505-01-159-4570
|
Daunorubicin Hydrochloride For I |
Mova Pharmaceutical Corp
|
|
Quote
|
|
NDC55390-0281-10
|
6505-01-159-4570
|
Daunorubicin Hydrochloride For I |
Falcon Pharmaceuticals Ltd
|
|
Quote
|
